Drreddys Laboratories | Salg Og Administrasjonskostnader



Selling And Administration Expenses Endring Dato
ANI Pharmaceuticals USD 69.72M 9.36M 2024-12
Aurora Cannabis CAD 38.18M 2.05M 2024-12
Bayer EUR 4.34B 610M 2024-12
Canopy Growth CAD 40.62M 308K 2024-12
Cipla INR 11.98B 102.6M 2024-12
Corcept Therapeutics USD 83.37M 9.63M 2024-12
Drreddys Laboratories INR 21.59B 436M 2024-12
GlaxoSmithKline GBP 2.66B 1.14B 2024-12
Hikma Pharmaceutical USD 280M 4M 2024-06
Novartis USD 3.5B 368M 2024-12
Pacira USD 79.61M 5.28M 2024-12
Prestige Brands USD 64.13M 3.35M 2024-12
Richter Gedeon HUF 51.12B 4.36B 2024-09
Sun Pharmaceuticals INR 25.52B 745.8M 2024-12
Supernus Pharmaceuticals USD 79.41M 9.66M 2024-12
Teva Pharmaceutical Industries USD 952M 28M 2024-12



Drreddys Laboratories Salg Og Administrasjonskostnader - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.